Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP — GEFCAPI04

Neoplasms, Unknown Primary Clinical Trial

Official title:
A Randomised Phase III Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With Carcinoma of an Unknown Primary (CUP)

Status Completed

Clinical Trial Summary

This is a european randomised, phase III, multi-centric study comparing a diagnostic and therapeutic strategy based on molecular analysis followed by suspected primary cancer tailored specific therapy, to an empiric strategy in patients with carcinoma of unknown primary. The purpose of this trial is to determine whether or not a strategy based on molecular analysis is effective in improving the progression free survival rates of patients with carcinoma of unknown primary (CUP).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Neoplasms, Unknown Primary

Clinical Trial Details

NCT number	NCT01540058
Study type	Interventional
Source	Gustave Roussy, Cancer Campus, Grand Paris
Contact
Status	Completed
Phase	Phase 3
Start date	March 22, 2012
Completion date	August 27, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04025970` - Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP
Completed	`NCT00193609` - Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site	Phase 2
Completed	`NCT00193596` - Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site	Phase 3
Completed	`NCT02628379` - Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Completed	`NCT01202786` - Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)	N/A
Not yet recruiting	`NCT00894569` - Paclitaxel/Carboplatin With or Without Cetuximab in CUP	Phase 2
Completed	`NCT00193622` - Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site	Phase 2